David Goldenberg, M.D., F.A.C.S.

Otolaryngology

Head and Neck Oncology and Surgery Thyroid and Parathyroid Surgery Minimally Invasive Radio Guided Parathyroid Surgery (MIRP) Revision and Reoperative Thyroid Surgery Salivary Gland Surgery daVinci Trans Oral Robotic Surgery (TORS)

David Goldenberg is a Head and Neck Surgical Oncologist. He was educated at the Ben Gurion University in Israel. He completed a residency in Otolaryngology-Head and Neck Surgery at Rambam Medical Center in Haifa, Israel and then went on to do a three year fellowship in Head and Neck Surgery and Oncology at the Johns Hopkins Hospital in Baltimore. Currently a Professor of both Surgery and Oncology at the Penn State College of Medicine, he serves as the director of Head and Neck Surgery at the Penn State Hershey Medical Center and director of the Head and Neck Cancer Team at the Penn State Cancer Institute in Hershey, PA.  He combines a surgical practice with teaching and research in head and neck and thyroid malignancies.

Clinical expertise is in the surgical care of patients with head and neck cancer, thyroid cancer as well as parathyroid disease.  Dr. Goldenberg is the only head and neck surgeon in the region performing Da Vinci TransOral Robotic Surgery (TORS) and Minimally invasive radioguided parathyroidecotmy (MIRP).

Research:  Dr. Goldenberg is an NIH funded researcher and a prolific author of articles and books in the field of head and neck and thyroid oncology and surgery.

Fellowship, Johns Hopkins University Hospital (2005) Residency, Rambam Medical Center (2002) Internship, Soroka Medical Center (1996) M.D., Ben Gurion University of the Negev (1995)

Hollenbeak CS, Wang L, Schneider P, Goldenberg D.
Outcomes of thyroid cancer in African Americans.
Ethn Dis. 2011 Spring;21(2):210-5. Choby G, Hollenbeak CS, Johnson S, Goldenberg D.
Surface electrode recurrent laryngeal nerve monitoring during thyroid surgery: normative values.
J Clin Neurophysiol. 2010 Feb;27(1):34-7. McLaughlin PJ, Zagon IS, Park SS, Conway A, Donahue RN, Goldenberg D.
Growth inhibition of thyroid follicular cell-derived cancers by the opioid growth factor (OGF) - opioid growth factor receptor (OGFr) axis.
BMC Cancer. 2009 Oct 18;9:369. Ondik MP, Dezfoli S, Lipinski L, Ruggiero F, Goldenberg D.
Secondary central compartment surgery for thyroid cancer.
Laryngoscope. 2009 Oct;119(10):1947-50. Goldenberg D, Brooksby C, Hollenbeak CS.
Age as a determinant of outcomes for patients with oral cancer.
Oral Oncol. 2009 Aug;45(8):e57-61. Epub 2009 Apr 9.